Literature DB >> 17899129

Pathophysiologic characteristics of balloon cells in cortical dysplasia.

Hyun-Sik Oh1, Min-Cheol Lee, Hyung-Seok Kim, Ji-Shin Lee, Jae-Hyuk Lee, Myeong-Kyu Kim, Young-Jong Woo, Jae-Hyoo Kim, Hyoung-Ihl Kim, Seung-Up Kim.   

Abstract

OBJECTS: Balloon cells are histopathological hallmarks of cortical malformations, i.e., focal cortical dysplasia (FCD) of the Taylor type or the cortical tubers of tuberous sclerosis, and they are believed to be the epileptogenic substrate and cause therapeutic drug resistant epilepsy in man. This study was carried out to investigate the developmental histogenesis and epileptogenesis of balloon cells in FCD.
MATERIALS AND METHODS: We used an immunohistochemical approach to examine the expressions of primitive neuroepithelial cell antigens (CD34, nestin, and vimentin), ionotrophic glutamate receptor subunits (NR1, NR2A/B, GluR1, GluR2, GluR3, GluR4, and GluR5/6/7), and P-glycoprotein in balloon cells from FCD and normal cerebral cortex epileptogenic lesions.
CONCLUSION: Balloon cells presented in clusters or as scattered cells throughout FCD lesions involving the gray and white matter. We found the balloon cells to be classifiable into three subtypes based on glial fibrillary acidic protein (GFAP) and neurofilament protein (NF-L) immunohistochemistry, i.e., as neuronal, astrocytic, and uncommitted. Immunopositivity for nestin, CD34, and vimentin in balloon cells of FCD suggests that they may be derived from the abnormal development and differentiation of neural stem cells. Moreover, it appears that epileptogenesis in cortical dysplasia is partly caused by the upregulations of some glutamate receptor subunit proteins (NR1, NR2A/B, GluR1, and GluR3) in balloon cells and dysplastic neurons. We speculate that the presence of the drug resistance protein P-glycoprotein in balloon cells might explain medically refractory epilepsy in FCD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899129     DOI: 10.1007/s00381-007-0453-z

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  48 in total

Review 1.  A classification scheme for malformations of cortical development.

Authors:  A J Barkovich; R I Kuzniecky; W B Dobyns; G D Jackson; L E Becker; P Evrard
Journal:  Neuropediatrics       Date:  1996-04       Impact factor: 1.947

Review 2.  Pathogenesis and pathology of focal malformations of cortical development and epilepsy.

Authors:  R I Kuzniecky; A J Barkovich
Journal:  J Clin Neurophysiol       Date:  1996-11       Impact factor: 2.177

3.  Abnormal cytoarchitecture of cortical dysplasia verified by immunohistochemistry.

Authors:  M Mizoguchi; T Iwaki; T Morioka; M Fukui; J Tateishi
Journal:  Clin Neuropathol       Date:  1998 Mar-Apr       Impact factor: 1.368

Review 4.  CD34: structure, biology, and clinical utility.

Authors:  D S Krause; M J Fackler; C I Civin; W S May
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

5.  Neuropathological findings in primary generalized epilepsy: a study of eight cases.

Authors:  H J Meencke; D Janz
Journal:  Epilepsia       Date:  1984-02       Impact factor: 5.864

6.  Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy.

Authors:  S M Sisodiya; W-R Lin; B N Harding; M V Squier; M Thom
Journal:  Brain       Date:  2002-01       Impact factor: 13.501

7.  Chordoid glioma of the third ventricle: immunohistochemical and molecular genetic characterization of a novel tumor entity.

Authors:  G Reifenberger; T Weber; R G Weber; M Wolter; A Brandis; K Kuchelmeister; P Pilz; E Reusche; P Lichter; O D Wiestler
Journal:  Brain Pathol       Date:  1999-10       Impact factor: 6.508

8.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

Authors:  A H Schinkel; E Wagenaar; C A Mol; L van Deemter
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

9.  Surgical pathology of drug-resistant partial epilepsy. A 10-year-experience with a series of 327 consecutive resections.

Authors:  Basile Pasquier; Michel Péoc'H; Blandine Fabre-Bocquentin; Lamia Bensaadi; Dominique Pasquier; Dominique Hoffmann; Philippe Kahane; Laura Tassi; Jean-François Le Bas; Alim Louis Benabid
Journal:  Epileptic Disord       Date:  2002-06       Impact factor: 1.819

10.  Expression of vimentin and glial fibrillary acidic protein in human developing spinal cord.

Authors:  Z Lukás; P Dráber; J Bucek; E Dráberová; V Viklický; Z Stasková
Journal:  Histochem J       Date:  1989-12
View more
  3 in total

1.  Increased expression of L-amino acid transporters in balloon cells of tuberous sclerosis.

Authors:  Byung-Chan Lim; Kyu-Young Cho; Joon-Seop Lim; Rae-Seop Lee; Hyung-Seok Kim; Myeong-Kyu Kim; Jae-Hyoo Kim; Young-Jong Woo; Jong-Keun Kim; Do Kyung Kim; Hyung-Ihl Kim; Kyung-Wha Lee; Min-Cheol Lee
Journal:  Childs Nerv Syst       Date:  2010-08-03       Impact factor: 1.475

2.  Increased expression of TRPC5 in cortical lesions of the focal cortical dysplasia.

Authors:  Guang-Zhen Xu; Hai-feng Shu; Hai-Yun Yue; Da-Hai Zheng; Wei Guo; Hui Yang
Journal:  J Mol Neurosci       Date:  2014-08-02       Impact factor: 3.444

3.  Clinical characteristics, pathological features and surgical outcomes of focal cortical dysplasia (FCD) type II: correlation with pathological subtypes.

Authors:  Kun Yao; Xi Mei; Xingzhou Liu; Zejun Duan; Changqing Liu; Yu Bian; Zhong Ma; Xueling Qi
Journal:  Neurol Sci       Date:  2014-04-18       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.